ARTICLE | Company News
Beyond Genomics, Elan in AD deal
May 15, 2001 7:00 AM UTC
Beyond Genomics ( Cambridge, Mass.) and ELN formed a joint venture to apply systems biology technologies to conduct Alzheimer's disease (AD) research. The two-year joint venture will identify biomarke...